Why the study?
Do chemotherapeutics induce shock proteins or inhibit protein synthesis in cultured cardiac myocytes?
Do chemotherapeutics induce shock proteins or inhibit protein synthesis in cultured cardiac myocytes?
In vitro testing suggests anthracyclines cause cardiotoxicity via protein synthesis depression, while high-dose cisplatin and methotrexate induce cellular stress responses.
Suggests anthracycline cardiotoxicity mechanism via protein synthesis inhibition; hypothesis-generating and should not yet change practice.
The de novo synthesis of 'shock proteins' is a cellular reaction towards toxic agents. Therefore, the induction of 'shock proteins' serves as a detector of toxicity on the level of protein synthesis. We investigated the effects of chemotherapeutics on cultured cardiac myocytes with this test system. Cisplatin (greater than or equal to 16 mumol/l) and methotrexate (greater than or equal to 1.4 mumol/l) evoked the de novo formation of a 30-kilodalton 'shock protein'. Doxorubicin (80-0.8 mumol/l) and daunomycin (90-0.9 mumol/l) inhibited protein synthesis almost completely. The other chemotherapeutic drugs tested did not influence heart cell protein formation even at concentrations widely above the pharmacological range. Our results indicate that the anthracyclines probably exert cardiotoxicity by depression of protein synthesis. Cisplatin and methotrexate are potentially cardiotoxic at high concentrations.
No takes yet. Share an insight, caveat, or question.
Löw‐Friedrich et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: